Press Release
Intravacc announces positive pre-clinical data for its OMV-based Lyme vaccine Bilthoven, the Netherlands, 13 April 2021 – Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, today announced positive preclinical data for its OMV based Lyme…
Intravacc announces positive preclinical data for its OMV-based Lyme vaccine- Neisserial OMV based Lyme vaccine elicit high antibody titers in mice
- Further evidence for Intravacc's versatile multi-disease OMV platform
- Data are published in peer reviewed journal Vaccine